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Background: Since implant placement on diabetic patients still is a controversial topic and systematic reviews are 
at the top of scientific evidence hierarchy, a thorough assessment of the methodological quality of these reviews 
must be performed to inform clinicians if their conclusions and recommendations can be followed on clinical 
practice. An overview of systematic reviews was performed with the purpose to assess the methodological quality 
of systematic reviews regarding dental implant placement on diabetic patients. In addition, we presented a synthe-
sis of clinical outcomes about the focused theme.
Material and Methods: An online search was performed on MEDLINE via PubMed, EMBASE, DARE-Cochrane, 
Scopus, Web of Science, LILACS, and SIGLE via Open Grey. Searches were conducted from database inception 
to May 2018. Systematic review articles with or without meta-analysis about the placement of dental implants on 
diabetic patients were included. Exclusion criteria were: articles whose primary outcome was not the survival/
success rate of dental implants on diabetic patients; studies that do not relate the survival/success rate of dental 
implants with diabetes; duplicated papers. Methodological quality assessment was performed with AMSTAR. A 
descriptive synthesis of clinical outcomes was performed.
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Introduction
Diabetes may interfere on dental implant osseointegra-
tion by suppressing osteoblastic differentiation, prolif-
eration, and activity on this process. In addition, it may 
change healing and immune response due to microangi-
opathies caused by hyperglycemia (1-3).
Although diabetes is historically seen as a risk factor 
for dental implant therapy, evidences from recent stud-
ies suggest that dental implant therapy is a safe option 
for oral rehabilitation in diabetic patients, since it al-
lows the patient to improve nutrition and the metabolic 
control, which is of the utmost importance for these pa-
tients (4,5).
Systematic reviews are at the top of scientific evidence 
hierarchy and their conclusions and recommendations 
are often followed by clinicians without a thorough 
judgement if these studies were properly methodologi-
cally conducted and if they present sound evidence to 
be safely followed on clinical practice (6,7).
Hence, this overview of systematic reviews was per-
formed to answer the focused question: what is the 
methodological quality of systematic reviews regarding 
dental implant placement in diabetic patients?
Material and Methods
The protocol of the present study was registered 
at the International Prospective Register of Sys-
tematic Reviews (PROSPERO) with the registra-
tion number CRD42018090890 (available at: http://
www.crd.york.ac.uk/PROSPERO/display_record.
php?ID=CRD42018090890). This overview was per-
formed following the recommendations of the Cochrane 
Collaboration Handbook for Systematic Reviews (8).
We conducted an overview of systematic reviews with 
the aim to determine the methodological quality of sys-
tematic reviews regarding dental implant placement on 
diabetic patients. In addition, we presented a synthesis 
of clinical outcomes in regard to the focused theme. 
Since this study is an overview of systematic reviews, 
whose sample is systematic review articles, it was not 
submitted to an ethics committee and it does not require 
an informed consent.  
Results: We identified 1.661 initial hits and eight articles were selected for overview (kappa=0.83; strong agreement). 
Six studies presented moderate methodological quality and two showed high methodological quality. Implant sur-
vival rate ranged from 31.8% to 100% and data from four meta-analysis showed that diabetes does not affect implant 
survival rate. On the other hand, data from two meta-analysis for marginal bone loss showed that diabetes statisti-
cally affects this outcome.
Conclusions: Two of the eight included studies presented high methodological quality and their meta-analysis showed 
that implant placement on diabetic patients does not affect implant survival rate and statistically affects marginal 
bone loss. However, clinicians must be aware that marginal bone loss values were not clinically relevant and may not 
be safe to follow the conclusions and recommendations of these studies. 
 
Key words: Dental implants, diabetes, systematic review, meta-analysis, survival rate.
The present study included systematic review articles 
with or without meta-analysis about the placement of 
dental implants on diabetic patients. Exclusion crite-
ria were: articles whose primary outcome was not the 
survival/success rate of dental implants on diabetic pa-
tients; studies that do not relate the survival/success rate 
of dental implants with diabetes; duplicated papers (pa-
pers found on more than one database). This systematic 
review did not establish restrictions regarding language 
or status of publications and was not influenced by per-
sons or institutions.
The search was performed on MEDLINE via PubMed, 
EMBASE, DARE-Cochrane, Scopus, Web of Science, 
LILACS, and SIGLE via Open Grey. Non-peer-re-
viewed literature (gray literature) was sought on SIGLE 
via Open Grey. Searches were conducted from database 
inception to May 2018. A comprehensive search strat-
egy was set individually for each database, as follows: 
- MEDLINE via PubMed: ((((((((((((((dental implants) 
OR implants, dental) OR dental implant) OR implant, 
dental) OR dental prostheses, surgical) OR dental pros-
thesis, surgical) OR surgical dental prosthesis) OR sur-
gical dental prosthesis) OR prostheses, surgical dental) 
OR prosthesis, surgical dental))))) AND (((((((((((((((((dia-
betes mellitus) OR diabetes mellitus, type 2) OR dia-
betes mellitus, noninsulin-dependent) OR diabetes 
mellitus, non insulin dependent) OR diabetes mellitus, 
non-insulin-dependent) OR non-insulin-dependent dia-
betes mellitus) OR diabetes mellitus, noninsulin depen-
dent) OR type 2 diabetes mellitus) OR type 2 diabetes) 
OR diabetes, type 2) OR diabetes mellitus, type 1) OR 
diabetes mellitus, insulin-dependent) OR diabetes mel-
litus, insulin dependent) OR insulin-dependent diabetes 
mellitus) OR type 1 diabetes mellitus) OR type 1 diabe-
tes) OR diabetes, type 1)
- EMBASE: (‘diabetes mellitus’/exp OR ‘diabetes’ OR 
‘diabetes mellitus’ OR ‘diabetic’) AND (‘tooth im-
plantation’/exp OR ‘dental implantation’ OR ‘dental 
implantation, endosseous’ OR ‘dental implantation, 
endosseous, endodontic’ OR ‘dental implantation, sub-
periosteal’ OR ‘immediate dental implant loading’ OR 
‘tooth implantation’ OR ‘tooth implant’/exp OR ‘dental 
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implant’ OR ‘dental implants’ OR ‘endosseous den-
tal implant’ OR ‘implant, teeth’ OR ‘implant, tooth’ 
OR ‘implants, teeth’ OR ‘implants, tooth’ OR ‘teeth 
implant’ OR ‘teeth implants’ OR ‘tooth implant’ OR 
‘tooth implants’)
- DARE-Cochrane: MeSH descriptor: [Dental Im-
plants] explode all trees or tooth implant:ti,ab,kw 
(Word variations have been searched) or tooth 
implantation:ti,ab,kw (Word variations have been 
searched) or diabetes:ti,ab,kw (Word variations have 
been searched)
- Web of Science: ts=(dental implant OR tooth implant 
OR tooth implantation) or ts=(diabetes OR diabetes 
mellitus)
- SCOPUS: ( TITLE-ABS-KEY ( “dental implant” ) 
OR  TITLE-ABS-KEY ( “tooth implant” )  OR  TI-
TLE-ABS-KEY ( “tooth implantation” )  AND  TITLE-
ABS-KEY ( “diabetes” )  OR  TITLE-ABS-KEY ( “dia-
betes mellitus” ) )
- LILACS: dental implant OR tooth implant OR tooth 
implantation OR implantação dentária AND Diabetes
- SIGLE via Open Gray: “dental implants” OR “tooth 
implant” OR “tooth implantation” AND “diabetes” 
Considering eligibility criteria, the search for eligible 
studies was conducted by two reviewers (O.B. and I.O.), 
which initially screened titles and/or abstracts in order 
to select potential eligible studies to be read fully. Final 
inclusion was then established, and references of se-
lected papers were also hand-searched. These reviewers 
tried to establish a consensus in cases of disagreements 
a third, and more experienced, reviewer (F.T.) was con-
sulted in situations where any disagreement persisted.
(9,10) 
Once papers were included for overview, a method-
ological quality assessment was performed by the same 
reviewers (O.B. and I.O.) using AMSTAR. This tool is 
composed of an 11-item questionnaire that focused on 
potential sources of bias regarding the review process 
and determines a final score that ranges from 0 to 11 
and represents the methodological quality of the review 
as high, moderate, or low (11-13). Specific items from 
AMSTAR and its classification system are described on 
Table 1. 
The primary outcome of the present overview was the 
methodological quality of included systematic reviews. 
Secondary outcomes were: implant survival/success 
rate, marginal bone loss, follow-up time, and patient’s 
age. Type of diabetes, number of patients and number of 
implants were complementary outcomes.
-Data analysis
An overview of systematic reviews does not require 
sample size calculation and, hence, it was not per-
formed. Cohen’s kappa analysis was performed to mea-
sure the level of agreement between reviewers on the 
selection of eligible studies. 
Methodological quality assessment with AMSTAR 
(primary outcome) was presented in a score from 0 to 
11 and classified as of high, moderate, or low method-
ological quality. 
Secondary outcomes were described as follows: implant 
survival/success rate as percentages, marginal bone loss 
in millimeters, follow-up range and patient’s age range 
in years; and type of diabetes was described according 
to author’s report.
Effect measures of systematic reviews that performed 
meta-analysis regarding implant failure and marginal 
bone loss were described, respectively, as relative risk 
or mean difference, each with its confidence interval 
and with values calculated for heterogeneity. 
Results
-Search and selection process
We identified 1.661 initial hits, which were distributed 
as follows: MEDLINE via PubMed= 299; EMBASE= 
355; Web of Science= 270; DARE-Cochrane= 203; Sco-
pus= 357; LILACS= 130; and SIGLE via Open Gray= 
47. After title and/or abstract reading, 1.612 papers were 
excluded. Then, the 49 remaining publications were 
read fully, and 41 articles were excluded. Finally, eight 
articles were selected for overview (4,5,14-19). Figure 
1 shows a synthesis of search and selection process as 
well as excluded papers and reasons for exclusions (20-
28).
Cohen’s Kappa statistics was calculated and showed an 
inter-reviewer agreement of 0.83, (strong agreement). 
-Methodological Quality Assessment
Of the eight selected papers, two were classified as of 
“high” methodological quality (Moraschini et al. and 
Chrcanovic et al.) (5,18) and six were of “moderate” 
methodological quality. Scores ranged from 5/11 (Kot-
sakis et al.) (14) from 10/11 (Moraschini et al. and Chr-
canovic et al.). 
Question 1 from AMSTAR received the lowest num-
ber of “Yes” answers (12,5%) and questions 5, 6, and 
7 from AMSTAR received the highest number of 
“Yes” answers (100% each). Overall positive answers 
(Yes answers) comprised 63,6% of results. Individual 
scores from each paper as well as specific items from 
AMSTAR and its classification system are described on 
Table 2. 
-Implant survival /success rate
Considering all included studies, implant survival rate 
ranged from 31.8% to 100%. However, Chen et al. (4) 
(relative risk=0.90; 95% confidence interval: 0.62 – 1.32; 
3 studies; 6.774 implants), Moraschini et al. (5) (relative 
risk=1.56; 95% confidence interval: 0.62 – 3.91; 7.904 
implants), Chrcanovic et al. (18) (relative risk=1.07; 95% 
confidence interval: 0.80 – 1.44; 12.814 implants), and 
Shi et al. (19) (relative risk=0.62; 95% confidence inter-
val: 0.22 – 1.70; 587 implants) performed meta-analysis 

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Med Oral Patol Oral Cir Bucal. 2019 Jul 1;24 (4):e483-90.                                                                                                                                                            Dental implants on diabetic patients
e487
Fig. 1: Flow chart showing steps performed to select eligible studies for overview.
for implant survival /success rate and did not present 
statistically significant results for this outcome, which 
showed that implant placement on diabetic patients does 
not affect implant survival rate (Table 3).
-Marginal bone loss
Chrcanovic et al. (mean difference= 0.20; 95% confi-
dence interval: 0.08-0.31) and Moraschini et al. (mean 
difference= 0.18; 95% confidence interval: 0.14-0.21) re-
ported data regarding marginal bone loss and performed 
meta-analysis for this outcome, which showed that im-
plant placement on diabetic patients affects marginal 
bone loss, with statistically significant results (Table 4). 
-Follow-up range and patient’s age range
One can see that five studies assessed patients with less 
than one year of follow-up, and the other three stud-
ies assessed patients with at least one or two years of 
follow-up. Four studies reported patient’s age, which 
ranged from 15 to 89 years. 
Discussion
An overview of eight systematic reviews regarding the 
placement of dental implants on diabetic patients was 
conducted. In addition, we presented a synthesis of clin-
ical outcomes about the focused theme. Our assessment 
with the AMSTAR tool determined that only two of the 
eight eligible reviews were classified as of high method-
ological quality and six were classified as of moderate 
methodological quality.
Although the studies of Moraschini et al. and Chrcanovic 
et al. (5,18) were classified as of “high” methodological 
quality and received the highest score between included 
studies (10/11), they did not mention if a protocol was 
developed a priori (question 1 from AMSTAR), which 
makes us question if the authors properly planned their 
reviews or if they changed methodology along the way. 
The findings from Chen et al. (4) (relative risk=0.90; 
95% confidence interval: 0.62 – 1.32; 3 studies; 6.774 
implants), Moraschini et al. (5) (relative risk=1.56; 95% 
confidence interval: 0.62 – 3.91; 7.904 implants), Chr-
canovic et al. (18) (relative risk=1.07; 95% confidence 
interval: 0.80 – 1.44; 12.814 implants), and Shi et al. 
(19) (relative risk=0.62; 95% confidence interval: 0.22 – 
1.70; 587 implants) indicate that diabetes does not affect 
implant survival rate. Nevertheless, these results must 
be carefully reviewed because two of these studies were 
classified as of moderate methodological quality, two 
presented clinical biases, and one performed meta-anal-
ysis of studies with a considerable amount of heteroge-
neity (I2=88%; p <0.00001). One must highlight that the 
results from Shi et al. (19) considered patients with well 
controlled diabetes and patients with poorly controlled 
diabetes, and the pooled meta-analysis showed that dia-
betes does not affect survival rate, regardless of glyce-
mic control. It’s also worth mentioning that Moraschini 
et al. (5) reported values of 31.8% for implant survival 
rate, which is considered as a very low rate and, even so, 
their meta-analysis also showed that diabetes does not 
affect implant survival rate. This meta-analysis identi-
fied on the funnel plot the study that caused such a low 
survival rate and did not go any further to reanalyze 
results without this study and/or to discuss what caused 
this outlier result. Thus, we considered that this may 
had strongly affected this meta-analysis results for im-
plant survival rate. 
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Effect Measures Heterogeneity
Study ID Effects 
Model
Outcome Value Confidence 
Interval
Test Value (%) P Value
Moraschini
et al. 2016





0.20 0.08-0.31 I2 81% .005
Effect Measures Heterogeneity
Study ID Effects 
Model
Outcome Value Confidence 
Interval















1.07 0.80-1.44 I2 9% .36
Shi
et al. 2016
Fixed Relative Risk 0.62 0.22-1.70 I2 Not
Reported
.437
Table 3: Results from meta-analysis regarding implant failure.
Table 4: Results from meta-analysis regarding marginal bone loss.
Additionally, results from Moraschini et al. (5) (mean 
difference= 0.18; 95% confidence interval: 0.14-0.21) 
and Chrcanovic et al. (18) (mean difference= 0.20; 95% 
confidence interval: 0.08-0.31) indicate that diabetes 
significantly affects marginal bone loss. One must high-
light that, despite the statistical significance of these re-
sults, they were not clinically relevant, since a loss of 
one fifth of a millimeter is a very low measure and may 
have occurred due to the surgical technique. Addition-
ally, besides clinical biases, these results were statisti-
cally combined with studies of moderate and high het-
erogeneity, respectively (Table 4). 
Regarding follow-up and patients’ age, a short and inad-
equate follow-up of less than one year was identified on 
several studies and the authors assessed patients still at 
a young age (15 years old). (5,15,17-19) A short follow-
up is a strong clinical bias because a dental implant may 
be lost on an earlier or on a later period, thus won’t be 
possible to identify implant loss after the short follow-
up. Since patients at a young age are on the stage of 
bone development, the placement of dental implants 
on these patients are also considered a source of bias. 
These flaws may have acted as confounding factors and 
may have influenced the results of several included re-
views, including the ones that were assessed as of high 
methodological quality.
An overview is a tertiary study that assesses secondary 
studies, which by their turn, gather data from primary 
publications. (6,7) Hence, the main limitation of the 
present study was the distance between tertiary and pri-
mary data, since an overview’s conclusions are drawn 
from secondary studies. Nevertheless, it becomes im-
portant to assess these secondary studies since they are 
often sought for clinical decision making and may be 
inadequately followed.
To the best of the authors’ knowledge, this is the first 
overview of systematic reviews regarding dental im-
plant placement on diabetic patients. Going forward, 
future systematic reviews must combine a high method-
ological quality with an unbiased selection of included 
studies with more precise eligibility criteria, also prop-
erly considering an adequate follow-up time and avoid-
ing young and elderly patients (age extremes). Also, 
clinical parameters that may indicate an early possibil-
ity of implant failure, such as bleeding on probing and 
presence of gingival infection must be considered for 
primary and secondary studies. This set of improve-
ments will provide robust scientific evidence for clini-
cal practice. 
Hence, the present overview of systematic reviews con-
cluded the following:
- Two of the eight included studies presented high meth-
odological quality and their meta-analysis showed that 
dental implant placement on diabetic patients does not 
affect implant survival and statistically affects marginal 
bone loss;
- Clinicians must be aware that marginal bone loss val-
ues were not clinically relevant and may not be safe to 
follow the conclusions and recommendations of these 
studies. 
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